Akers Biosciences Total Revenue

Akers Biosciences (AKER) currently reports a total revenue of $500K as of December 2020. That compares with $2.9M in the prior-year period — down 82.8% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Akers Biosciences's total revenue history and peer comparisons.

Akers Biosciences's total revenue decreased from $2.9M to $500K — a 82.8% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akers Biosciences's total revenue of $500K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Akers Biosciences reported $500K in total revenue as of December 2020. That compares with $2.9M in the prior-year period — down 82.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $500K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.